bioprosthetic valves are preferred over mechanical valves by physicians and patients. Recently, more than 80% of all surgically implanted valves are biologic substitutes.2, 5-7 Even industry adopted this trend and brought “v...
Rapid restoration of thrombus formation and high-molecular-weight von Willebrand factor multimers in patients with severe aortic stenosis after valve replacement[J]. J Atheroscler Thromb, 2016, 23(10): 1150-1158. [11] Zhang Y, Wang VY...
Mechanical valveOn-XSAVRTAVRPatients who need a prosthetic aortic heart valve may decide, working with their cardiologist and cardiac surgeon, among a variety of options: surgical or transcatheter approach, bioprosthetic or mechanical valve, or a Ross procedure if suitable to their age and anatomy....
SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement No drug interventions Not Available Not Available recruiting NCT04464356 Application of Emergent Peripheral Mechanical Circulatory Support in Transcatheter Aortic Valve Replacement for 6 Patients No drug interventi...
a blood clot that requires treatment, damage to the valve (e.g., wear, breakage, recurring aortic stenosis), valve issues not related to structure (e.g., leakage, inappropriate sizing or positioning, blockage, excess tissue in growth, blood cell damage) or mechanical failure of the delivery...
The type of prior SMVR (repair, bioprosthetic replacement, or mechanical replacement) had no impact on 30-day or 1-year survival. Conclusions: Patients with prior SMVR undergoing TAVR had similar 30-day outcomes, slightly higher 1-year mortality, and no increase in early PVL compared to ...
Historically, the only effective treatment was open surgical aortic valve replacement (SAVR), typically with the choice of either a bioprosthetic or a mechanical valve to replace the function of the native aortic valve. Mechanical valves have excellent durability but are limited by valve thrombosis, ...
Indeed, their trial excluded people with a mechanical heart valve, recent venous thromboembolism, among other groups. Even so, POPular PAUSE TAVI "finally denies" the observational TAVR studies that had suggested no increased risk of bleeding or vascular complications with continuing OAC, according to...
This review provides an in-depth analysis of the effect of length of stay (LOS), comorbidities, and procedural complications on the cost-effectiveness of transcatheter aortic valve replacement (TAVR) in comparison to surgical aortic valve replacement (SAVR). We found that the average LOS was ...
Mechanical surgical valves should not be forgotten as an excellent option with long-term durability in low-risk young patients, as it is well known that all bioprostheses degenerate more intensively in this patient group. Therefore, finding a valve with longer durability should be our primary goal...